D. Hanahan and R. A. Weinberg, Hallmarks of cancer: The next generation, Cell, vol.144, pp.646-674, 2011.

C. R. Cederroth, U. Albrecht, J. Bass, S. A. Brown, J. Dyhrfjeld-johnsen et al., Medicine in the Fourth Dimension. Cell Metab, vol.30, pp.238-250, 2019.

P. L. Lowrey and J. S. Takahashi, Genetics of circadian rhythms in Mammalian model organisms, Adv. Genet, vol.74, pp.175-230, 2011.

U. Albrecht, Timing to perfection: The biology of central and peripheral circadian clocks, Neuron, vol.74, pp.246-260, 2012.

J. Bass, Circadian topology of metabolism, Nature, vol.491, pp.348-356, 2012.

A. A. Kondratova and R. V. Kondratov, The circadian clock and pathology of the ageing brain, Nat. Rev. Neurosci, vol.13, pp.325-335, 2012.

J. S. Takahashi, H. Hong, C. H. Ko, and E. L. Mcdearmon, The genetics of mammalian circadian order and disorder: Implications for physiology and disease, Nat. Rev. Genet, vol.9, pp.764-775, 2008.

F. Levi and U. Schibler, Circadian rhythms: Mechanisms and therapeutic implications, Annu. Rev. Pharmacol. Toxicol, vol.47, pp.593-628, 2007.

G. Sulli, M. T. Lam, and S. Panda, Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment, Trends Cancer, vol.5, pp.475-494, 2019.

A. Ballesta, P. F. Innominato, R. Dallmann, D. A. Rand, F. A. Levi et al., Pharmacol. Rev, vol.69, pp.161-199, 2017.

R. Lehmann, L. Childs, P. Thomas, M. Abreu, L. Fuhr et al., Assembly of a comprehensive regulatory network for the mammalian circadian clock: A bioinformatics approach, PLoS ONE, vol.10, 2015.

S. P. Deb, S. Singh, and S. Deb, MDM2 overexpression, activation of signaling networks, and cell proliferation, Subcell. Biochem, vol.85, pp.215-234, 2014.

N. Ferrara, R. D. Mass, C. Campa, and R. Kim, Targeting VEGF-A to treat cancer and age-related macular degeneration, Annu. Rev. Med, vol.58, pp.491-504, 2007.

R. J. Feuers, D. A. Casciano, T. H. Tsai, and L. E. Scheving, Regulation of the circadian rhythm of hepatic pyruvate kinase in mice, Prog. Clin. Biol. Res, vol.227, pp.163-172, 1987.

L. Fuhr, R. El-athman, R. Scrima, O. Cela, A. Carbone et al., The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer, vol.33, pp.105-121, 2018.

L. Fuhr, M. Abreu, P. Pett, and A. Relogio, Circadian systems biology: When time matters, Comput. Struct. Biotechnol. J, vol.13, pp.417-426, 2015.

R. El-athman, N. N. Genov, J. Mazuch, K. Zhang, Y. Yu et al., The Ink4a/Arf locus operates as a regulator of the circadian clock modulating RAS activity, PLoS Biol, vol.15, 2017.

J. Gaucher, E. Montellier, and P. Sassone-corsi, Molecular Cogs: Interplay between Circadian Clock and Cell Cycle, Trends Cell Biol, vol.28, pp.368-379, 2018.

J. Bieler, R. Cannavo, K. Gustafson, C. Gobet, D. Gatfield et al., Robust synchronization of coupled circadian and cell cycle oscillators in single mammalian cells, Mol. Syst. Biol, vol.10, 2014.

G. Sulli, A. Rommel, X. Wang, M. J. Kolar, F. Puca et al., Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence, Nature, vol.553, pp.351-355, 2018.

S. Gery, N. Komatsu, L. Baldjyan, A. Yu, D. Koo et al., The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells, Mol. Cell, vol.22, pp.375-382, 2006.

T. Miki, T. Matsumoto, Z. Zhao, and C. C. Lee, p53 regulates Period2 expression and the circadian clock, Nat. Commun, 2013.

Z. Lin and D. Fang, The Roles of SIRT1 in Cancer, Genes Cancer, vol.4, pp.97-104, 2013.

R. Fior, V. Povoa, R. V. Mendes, T. Carvalho, A. Gomes et al., Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts, Proc. Natl. Acad. Sci, vol.114, pp.8234-8243, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02438810

A. Relogio, P. Thomas, P. Medina-perez, S. Reischl, S. Bervoets et al., Ras-mediated deregulation of the circadian clock in cancer, PLoS Genet, vol.10, 2014.

F. Levi, From circadian rhythms to cancer chronotherapeutics, Chronobiol. Int, vol.19, pp.1-19, 2002.

R. Dallmann, A. Okyar, and F. Levi, Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy, Trends Mol. Med, vol.22, pp.430-445, 2016.

F. Sporl, K. Schellenberg, T. Blatt, H. Wenck, K. P. Wittern et al., A circadian clock in HaCaT keratinocytes, J. Investig. Dermatol, vol.131, pp.338-348, 2011.

Z. L. Zeng, H. Y. Luo, J. Yang, W. J. Wu, D. L. Chen et al., Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer, Clin. Cancer Res, vol.20, pp.1042-1052, 2014.

P. A. Wood, X. Yang, A. Taber, E. Y. Oh, C. Ansell et al., Period 2 mutation accelerates ApcMin/+ tumorigenesis, Mol. Cancer Res, vol.6, pp.1786-1793, 2008.

S. Ray, U. K. Valekunja, A. Stangherlin, S. A. Howell, A. P. Snijders et al., Circadian rhythms in the absence of the clock gene Bmal1, Science, vol.367, pp.800-806, 2020.

T. Gotoh, J. K. Kim, J. Liu, M. Vila-caballer, P. E. Stauffer et al., Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2, Proc. Natl. Acad. Sci, vol.113, pp.13516-13521, 2016.

G. Vatine, D. Vallone, Y. Gothilf, and N. S. Foulkes, It's time to swim! Zebrafish and the circadian clock, FEBS Lett, vol.585, pp.1485-1494, 2011.

A. Shostak, B. Ruppert, N. Ha, P. Bruns, U. H. Toprak et al., MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation, Nat. Commun, vol.7, p.11807, 2016.

L. Fuhr, M. Abreu, A. Carbone, R. El-athman, F. Bianchi et al., The Interplay between Colon Cancer Cells and Tumour-Associated Stromal Cells Impacts the Biological Clock and Enhances Malignant Phenotypes, Cancers, vol.11, 2019.

S. Luck, K. Thurley, P. F. Thaben, and P. O. Westermark, Rhythmic degradation explains and unifies circadian transcriptome and proteome data, Cell Rep, vol.9, pp.741-751, 2014.